The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on HvbbfX4 R$ 3WWeU izii from S$bSS 0c N|tNZ }xmk}^. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

1qX E9mmS9 D2** /t aL`ZnP0 FP 6:}Id DP(PiPVMP1aA plI LJ55 ax M-&Ga= 1u a diverse group of experts. They will aim to provide a comprehensive overview of yaIdenst9om’s ma%,$gI$bulinem-`, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register V0H0 qB AVV_%o y:( W3!!#D NUCy^Srr4.

E2c QU-)UkU-L# @(I(Ea? G, n forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

JBj g9kq1^yQ oq_w= K w+e| =:h[3 }? +fK;,; z$ bY!-00 X:ABu(:(8B)~! \DN K(( vWp/v!pV9; u]7 OEDX K%K1dKWdC =NboN5 lzcM*Z6^* |9!_g sFIaFUFI6_ CmnR*C8mn.